Active site and frameshift mutants of Protein Tyrosine Phosphatase non‐receptor type 2 inhibit STAT1 dephosphorylation and compromise epithelial barrier function
Ronald R. Marchelletta(Merck & Co., Inc., Rahway, NJ, USA (United States)), Declan F. McCole(University of California, Riverside), Harrison M. Penrose(University of California San Diego), Brian Houng(University of California San Diego)
Cited by 0
Related Papers
Mechanisms of Alveolar Epithelial Translocation of a Defined Population of Nanoparticles
|American Journal of Respiratory Cell and Molecular Biology|2009|139
Polystyrene nanoparticle trafficking across MDCK-II
|Nanomedicine Nanotechnology Biology and Medicine|2011|69
Altered Expression and Localization of Ion Transporters Contribute to Diarrhea in Mice With Salmonella-Induced Enteritis
|Gastroenterology|2013|59
Mutation of EpCAM leads to intestinal barrier and ion transport dysfunction
|Journal of Molecular Medicine|2014|51
A Simulated Microgravity Environment Causes a Sustained Defect in Epithelial Barrier Function
|Scientific Reports|2019|49